NCT00098982View on ClinicalTrials.gov

Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

January 31, 2007

Conditions

Colorectal Cancer

Interventions

DRUG

bortezomib

DRUG

fluorouracil

DRUG

leucovorin calcium

DRUG

oxaliplatin

Trial Locations (3)

80131

Istituto Nazionale per lo Studio e la Cura dei Tumori, Naples

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00098982 - Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter